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Background: Fecal microbiota transplantation (FMT) is an effective treatment for recurrent Clostridium difficile
infection and shows promise for treating other medical conditions associated with intestinal dysbioses. However,
we lack a sufficient understanding of which microbial populations successfully colonize the recipient gut, and the
widely used approaches to study the microbial ecology of FMT experiments fail to provide enough resolution to
identify populations that are likely responsible for FMT-derived benefits.
Methods: We used shotgun metagenomics together with assembly and binning strategies to reconstruct
metagenome-assembled genomes (MAGs) from fecal samples of a single FMT donor. We then used metagenomic
mapping to track the occurrence and distribution patterns of donor MAGs in two FMT recipients.
Results: Our analyses revealed that 22% of the 92 highly complete bacterial MAGs that we identified from the
donor successfully colonized and remained abundant in two recipients for at least 8 weeks. Most MAGs with a high
colonization rate belonged to the order Bacteroidales. The vast majority of those that lacked evidence of
colonization belonged to the order Clostridiales, and colonization success was negatively correlated with the
number of genes related to sporulation. Our analysis of 151 publicly available gut metagenomes showed that the
donor MAGs that colonized both recipients were prevalent, and the ones that colonized neither were rare across
the participants of the Human Microbiome Project. Although our dataset showed a link between taxonomy and
the colonization ability of a given MAG, we also identified MAGs that belong to the same taxon with different
colonization properties, highlighting the importance of an appropriate level of resolution to explore the functional
basis of colonization and to identify targets for cultivation, hypothesis generation, and testing in model systems.
Conclusions: The analytical strategy adopted in our study can provide genomic insights into bacterial populations
that may be critical to the efficacy of FMT due to their success in gut colonization and metabolic properties, and
guide cultivation efforts to investigate mechanistic underpinnings of this procedure beyond associations.
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Fecal microbiota transplantation (FMT), the transference
of fecal material from a healthy donor to a recipient, has
gained recognition as an effective and relatively safe treat-
ment for recurrent or refractory Clostridium difficile
infection (CDI) [1–8]. Its success in treating CDI sparked
interest in investigating FMT as a treatment for other
medical conditions associated with intestinal dysbiosis,
such as ulcerative colitis [9–11], Crohn’s disease (CD)
[12–14], irritable bowel syndrome (IBS) [15, 16], and
others, including metabolic syndrome [17], neurodevelop-
mental [18], and autoimmune disorders [19]. Despite the
excitement due to its therapeutic potential, FMT also pre-
sents challenges for researchers and clinicians with poten-
tial adverse outcomes, including the transfer of infectious
organisms [20] or contaminants from the environment
[21, 22]. A complete understanding of FMT from a basic
science perspective is still lacking, as we have yet to deter-
mine the key microbial populations that are responsible
for beneficial outcomes, as well as adverse effects.
Recent advances in high-throughput sequencing
technologies, molecular approaches, and computation
have dramatically increased our ability to investigate the
ecology of microbial populations. Utilization of these
advances at a proper level of resolution can lead to a
better mechanistic understanding of FMT and identify
new therapeutic opportunities or address potential risks.
Most current studies on FMT use amplicons from
marker genes, such as the 16S ribosomal RNA gene, to
characterize the composition of microbial communities
[23–26]. While providing valuable insights into the
broad characteristics of FMTs, amplicons from the 16S
ribosomal RNA gene do not offer the resolution to
effectively identify populations that colonize recipients
[27]. Other studies use shotgun metagenomics to annotate
short reads and map them to reference genomes in order
to track changes in the functional potential or mem-
bership in the gut microbial communities of recipients
[28–30]. In a recent study, Li et al. [30] demonstrated the
coexistence of donors and recipients’ gut microbes
3 months after FMT by mapping short metagenomic reads
to reference genomes. Although this approach provides
more information than marker gene amplicons alone, it is
subject to the limitations and biases of reference genomic
databases, is unable to characterize populations that do not
have closely related culture representatives, and does not
provide direct access to the genomic context of relevant
populations for more targeted follow-up studies.
Metagenomic assembly and binning [31, 32] is an
alternative approach to characterizing microbial commu-
nities through marker gene amplicons or reference ge-
nomes. Here, we used the state-of-the-art metagenomic
assembly and binning strategies to reconstruct microbial
population genomes directly from a single FMT donorand tracked the occurrence of resulting metagenome-
assembled genomes (MAGs) in two FMT recipients up
to 8 weeks.
Methods
Sample collection, preparation, and sequencing
We collected a total of 10 fecal samples; four samples
from a single donor “D” (a 30-year-old male) and three
samples from each of the two recipients “R01” (a 23-
year-old male) and “R02” (a 32-year-old female) before
and after FMT. Recipient samples originated from time
points pre-FMT, 4 weeks after FMT, and 8 weeks after
FMT, while four samples from the donor were collected
on four separate days 2 weeks prior to the transplant-
ation. All fecal samples were handled under anaerobic
conditions prior to transplantation, and the recipients
had no genetic relationship to the donor. Through a single
colonoscopy for each recipient, the donor sample DS 01
was transferred to R01, and the donor sample DS 04 was
transferred to R02. All samples were stored at −80 °C until
DNA extraction. We extracted the genomic DNA from
frozen samples according to the centrifugation protocol
outlined in MoBio PowerSoil kit with the following modi-
fications: cell lysis was performed using a GenoGrinder to
physically lyse the samples in the MoBio Bead Plates
and Solution (5–10 min). After final precipitation, the
DNA samples were resuspended in TE buffer and
stored at −20 °C until further analysis. We prepared
our shotgun metagenomic libraries with OVATION
Ultralow protocol (NuGen) and used an Illumina
NextSeq 500 platform to generate 2 × 150 nt paired-
end sequencing reads.
Metagenomic assembly and binning
We removed the low-quality reads from the raw sequen-
cing results using the program “iu-filter-quality-minoche”
in illumina-utils [33] (available from https://github.com/
merenlab/illumina-utils) according to Minoche et al. [34].
We then co-assembled reads from the donor samples
using MEGAHIT v1.0.6 [35], used Centrifuge v1.0.2-beta
[36] to remove contigs that matched to human genome,
and mapped short reads from each recipient and donor
sample to the remaining contigs using Bowtie2 v2.0.5 [37].
We then used anvi’o v2.3.1 (available from http://merenla-
b.org/software/anvio) to profile mapping results, finalize
genomic bins, and visualize results following the workflow
outlined in Eren et al. [38]. Briefly, (1) the program “anvi-
gen-contigs-database” profiled our contigs using Prodigal
v2.6.3 [39] with default settings to identify open reading
frames and HMMER [40] to identify matching genes in
our contigs to bacterial [41] and archaeal [42] single-copy
core gene collections, (2) “anvi-init-bam” converted map-
ping results into BAM files, (3) “anvi-profile” processed
each BAM file to estimate the coverage and detection
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(4) “anvi-merge” combined profiles from each sample to
create a merged anvi’o profile for our dataset. We used
“anvi-cluster-with-concoct” for the initial binning of con-
tigs using CONCOCT [44] by constraining the number of
clusters to 10 (“–num-clusters 10”) to minimize the “frag-
mentation error” (where multiple bins describe one popu-
lation). We then interactively refined each CONCOCT
bin that exhibit “conflation error” (where one bin de-
scribes multiple populations) using the program “anvi-re-
fine” based on tetra-nucleotide frequency, taxonomy,
mean coverage, and completion and redundancy estimates
based on bacterial and archaeal single-copy genes. We
classified a given genome bin as a “metagenome-assem-
bled genome” (MAG) if it was more than 70% complete
or larger than 2 Mbp, and its redundancy was estimated
to be less than 10%. We used “anvi-interactive” to visualize
the distribution of our bins across samples and “anvi-
summarize” to generate static HTML output for binning
results. Besides anvi’o, we also used CheckM v1.0.7 [45] to
assess the completion and contamination of our bins.
Taxonomic and functional annotation of MAGs
We employed multiple approaches to infer taxonomy.
Besides the taxonomic annotations reported by CheckM,
we searched amino acid sequences for the RecA gene for
each MAG in the National Center for Biotechnology
Information (NCBI) databases. We also used Phylosift
v1.0.1 [46] to determine the phylogenomic relationships
between our MAGs and a collection of 1758 reference
genomes (with no redundancy at the species level)
that we acquired from the Ensembl database [47]
(Additional file 1: Table S3). Briefly, Phylosift (1)
identifies a set of 37 marker gene families in each
genome, (2) concatenates the alignment of each
marker gene family across genomes, and (3) computes
a phylogenomic tree from the concatenated alignment
using FastTree [48]. Lastly, we used FigTree v1.4.3 (http://
tree.bio.ed.ac.uk/software/figtree/) to finalize the phyloge-
nomic tree for publication. We used RAST [49] to ascribe
functions to our MAGs.
Criteria for detection and colonization of MAGs in the
recipients
For each genome bin, anvi’o reports the percentage of
nucleotide positions in all contigs that are covered by at
least one short read based on mapping results. This statis-
tic gives an estimate of “detection” regardless of the cover-
age of a given genome bin. We required the detection
statistic of a genome bin to be at least 25% to consider it
“detected” in a given sample. This prevented inflated
detection rates due to non-specific mapping, which is not
uncommon due to relatively well-conserved genes across
gut populations. Finally, we conservatively decided that aMAG was transferred from the donor and colonized a
given recipient successfully only if (1) it was detected in
both samples that were collected from the recipient at 4
and 8 weeks after the FMT and (2) it was not detected in
the pre-FMT sample from the same recipient.
The use of HMP metagenomes
We used 151 Human Microbiome Project (HMP) gut
metagenomes [50] to estimate the detection of our
MAGs and to compare the taxonomic profiles of our
metagenomes in the context of the HMP participants.
To estimate detection, we mapped HMP metagenomes
to our MAGs using Bowtie2 with default parameters
and considered a MAG to be detected in a given HMP
metagenome when its level of detection surpassed 25%.
We also annotated our metagenomes and HMP gut
metagenomes using MetaPhlAn2 [51]. Additionally, to
estimate the contribution of donor MAGs to recipient
taxonomic profiles, we used the 60 and 83 MAGs that
were not detected pre-FMT in samples of R01 and R02
to recruit and remove reads from the post-FMT R01 and
R02 metagenomes. MetaphlAn2 estimated the taxonom-
ical profiles of the remaining reads. Additional file 1:
Table S3 reports taxonomic annotations.
Statistical analyses
We performed cluster analyses on distribution profiles
of MAGs using the R library vegan with Bray-Curtis dis-
tances of normalized values. We used the PERMANOVA
(R adonis vegan) [52] test to measure the degree of simi-
larity of the bacterial communities between the samples
in the study. We further used similarity index (SIMPER)
analysis to identify the taxa that contributed the highest
dissimilarity between the samples. We classified the
MAGs into four main groups based on their colonization
characteristics in the recipients. We then performed a
Wilcoxon signed-rank test (STAMP) [53] with Benjamini-
Hochberg FDR (false discovery rate) correction for mul-
tiple tests on the total-sum normalized data to ascertain
any significant differences in the functional potential
between the groups and carried out canonical correspond-
ence analysis based on functional potential and the MAGs’
colonization characteristics.
Results
The shotgun sequencing of genomic DNA from 10 fecal
samples resulted in a total of 269,144,211 quality-filtered
2 × 150 paired-end metagenomic reads (Additional file 2:
Table S1). By co-assembling the donor samples, which
corresponded to 115,037,928 of the quality-filtered
reads, we recovered 51,063 contigs that were longer than
2.5 kbp and organized them into 444 genomic bins
comprising a total of 442.64 Mbp at various levels of
completion (Additional file 2: Table S1, Additional file 3:
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nated 92 of our genomic bins as metagenome-assembled
genomes (MAGs) (Fig. 1, Additional file 2: Table S1).
Four major patterns emerged from the distribution of
MAGs across individuals: MAGs that colonized both
recipients R01 and R02 (group I, n = 20), MAGs that
colonized only R01 (group II, n = 11), only R02 (group
III, n = 8) and MAGs that did not colonize either of the
recipients (group IV, n = 13) (Fig. 1). We found no cor-
relation between the abundances of MAGs in donorFig. 1 Distribution of MAGs across samples and HMP metagenomes. a The 9
circles) as well as two recipients (R01 and R02) before FMT (pre-FMT), 4 weeks
colors in donor and recipient layers indicate the level of detection of a given
order-level taxonomy for each MAG. Selections in a represent four groups of
onized both recipients, group II with 11 MAGs that colonized only R01, group
MAGs that colonized neither recipient. b The detection for each contig in two
coverage of each nucleotide position in two example contigs from the MAGs
HMP gut metagenomes and detection of MAG 54 (group I) and MAG 26 (grosamples and their success at colonizing recipients
(ANOVA, F = 0.717, p = 0.543). Additional file 2: Table S1
reports the detection and mean coverage statistics for each
MAG in each group. Both of our recipients had mild/
moderate ulcerative colitis (R01 had proctitis and R02 had
left-sided/distal colitis), and both of them showed a de-
crease in intestinal inflammation after FMT. R01 had an
initial fecal calprotectin count of 26 prior to FMT,
which decreased to <17 at week 4 (no data was col-
lected at week 8), and R02’s fecal calprotectin count2 MAGs and their level of detection in four donor samples (four inner
after FMT (W4), and 8 weeks after FMT (W8). Rectangles with red and blue
MAG in a given sample. The outermost two layers display the genus- and
MAGs based on their distribution patterns: group I with 20 MAGs that col-
III with 8 MAGs that colonized only R02, and finally, group IV with 13
example MAGs summarized to a single detection value in a. c The
displayed in b. d The prevalence of MAGs in groups I and IV across 151
up IV) in HMP gut metagenomes as two examples
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4 (W4) and week 8 (W8), respectively.
The taxonomy of 14 of the 20 MAGs that colonized
both recipients resolved to the order Bacteroidales
(Fig. 1). Besides Bacteroidales, group I also included five
MAGs that were classified as order Clostridiales and one
MAG as Coriobacteriales. CheckM partitioned the group
I MAGs into Bacteroides (n = 5), Alistipes (n = 5),
Odoribacter (n = 1), Paraprevotella (n = 1), and Barne-
siella (n = 1). Seven MAGs were not assigned to a
specific genus in this group. In contrast to the
Bacteroidales-dominated group I, 10 of the 13 MAGs
that did not colonize recipients (group IV) resolved to
the order Clostridiales. The remaining three MAGs were
not assigned any taxonomy at the order level. The only
genus-level annotation for the MAGs in group IV was
Ruminococcus (n = 2). Overall, CheckM did not assign
any genus-level taxonomy to 18 of the 33 MAGs in
group I and group IV. MAGs that colonized only one of
the two recipients did not show a consistent taxonomic
signal: while 9 of 11 MAGs that colonized only R01
(group II) were assigned to the order Clostridiales,
only 4 of 8 MAGs that only colonized R02 (group
III) were assigned to that order (Fig. 1, Additional
file 2: Table S1). The remaining MAGs in group III
were assigned to orders Bacteroidales (n = 2) and
Burkholderiales (n = 1), and one of them did not re-
solve to any order-level taxon (n = 1). We also
employed a phylogenomic approach to investigate the
validity of the taxonomy of our MAGs with respect
to reference genomes (Additional file 4: Figure S2). All
order-level taxonomic annotations by CheckM were con-
sistent with the phylogenomic placement of our MAGs.
We resolved inconsistencies at the genus-level by remov-
ing annotations that differed between approaches.
We used the Human Microbiome Project gut metagen-
omes to investigate whether the differential colonization
outcomes we observed for donor MAGs were representa-
tive of their occurrence in healthy individuals. Our ana-
lysis of 151 publicly available gut metagenomes showed
that the donor MAGs in group I that colonized both
recipients were more prevalent, and the ones in group IV
that colonized neither of the recipients were more
rare across the participants of the HMP (ANOVA, F =
10.04, p < 0.001; Fig. 1). In fact, while the group I MAGs
occurred in 40.63% (±26.67%) of the individuals, the group
IV MAGs showed more sporadic patterns as they were
detected in only 10.39(±5.69%) of the HMP metagenomes
(Fig. 1, Additional file 1: Table S3, Additional file 5:
Figure S3). These results suggest that the relevance of
the donor MAGs we recovered here are not necessarily
limited to our study and represent a subset of popula-
tions with patterns of high- and low-colonization
success.We then investigated whether there was a link between
the functional potential of MAGs and their success of
colonization. The canonical correspondence analysis
(CCA) of 500 functions and 107 sub-systems (Additional
file 6: Table S2) revealed that the group I MAGs possessed
a higher relative abundance of genes coding for quinone
cofactors, along with functions involving lipoic acid
synthesis and metabolism of aromatic compounds. In
contrast, the group IV MAGs carried higher number of
genes related to dormancy and sporulation, spore DNA
protection, and motility and chemotaxis (pseudo-F =
2.156, p < 0.0001). Interestingly, MAGs that were trans-
ferred to only R01 (group II) also carried higher numbers
of genes for dormancy and sporulation and spore DNA
protection (Fig. 2, Additional file 6: Table S2). The
functional similarity between group II and group IV
MAGs was also mirrored with their detection rate across
the HMP metagenomes (Additional file 1: Table S3,
Additional file 5: Figure S3). This suggests that despite
strong signal, the functional potential is not a robust
predictor of colonization success and individuals may
respond differently to the same donor.
We also investigated to what extent the recipients be-
came donor-like after the FMT. As expected, the ana-
lysis based on the mean coverage of donor MAGs
suggested an increased similarity between the donor and
recipients after the FMT (Fig. 3a). Mapping metage-
nomic short reads to donor MAGs offers a limited
insight into the recipient microbial populations. To
minimize any potential biases, we also generated genus-
level taxonomic profiles for donor and recipient samples
by annotating all metagenomic short reads. This strategy
also allowed us to compare our donor, as well as our re-
cipients before and after FMT, to the larger context of
the HMP cohort (Fig. 3b). This analysis suggested that
the donor samples showed no discernible differences
from the HMP cohort (PERMANOVA, pseudo-F =
1.489, p = 0.110). In contrast, the pre-FMT samples of
both recipients differed significantly from the HMP co-
hort and from the donor samples (PERMANOVA,
pseudo-F = 4.470, p = 0.001). However, the recipient
samples after FMT no longer differed from the HMP co-
hort (PERMANOVA, pseudo-F = 1.395, p = 0.168)
(Fig. 3b). Based on the taxonomic profiles from short
metagenomic reads, both recipients were more than 60%
similar to the donor microbiota after FMT. Similarity
percentage analysis (SIMPER) of the taxonomic profiles
suggested that the two recipients were 79.60% similar
after FMT and that Bacteroides was responsible for the
largest fraction (32.42%) of difference between recipient
samples of pre-FMT and 4 weeks after FMT. There were
no significant changes in the recipients’ taxonomic pro-
files between W4 and W8 after FMT (PERMANOVA,
pseudo-F = 0.221, p = 0.631). These results show that our
Fig. 2 Canonical correspondence analysis of functions in four groups of MAGs. The 39 significant functional subcategories are shown
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came more like the HMP cohort following FMT. Yet,
one important question remains: to what extent this
convergence is due to donor MAGs and not due to the
changing abundance of the initially rare members of the
recipient microbial populations? To investigate this, we
first identified donor MAGs that were not detected in a
given recipient’s pre-FMT metagenome and removed
short reads from the recipient’s W4 and W8 metagen-
omes after FMT. We then characterized the taxonomic
profiles with the remaining reads (Fig. 3c). Without
reads matching to donor MAGs, the taxonomic profiles
for the samples collected after FMT remained close to
the pre-FMT status, and dissimilar to both the donor
and HMP metagenomes, suggesting a more important
contribution of the donor populations to the conver-
gence rather than the emergence of initially rare recipi-
ent populations. This was particularly apparent for R01,
for which the taxonomic profiles before and after FMT
at W8 were highly dissimilar (R2 of 0.122) yet became
more alike after the subtraction of reads matching to
donor MAGs (R2 of 0.634). Taking into account the fact
that 92 MAGs are only a subset of the 444 bins we ini-
tially recovered from the donor, we tested whether these
trends remained similar when all 444 metagenomic
bins were used for removal of short reads and con-
firmed that the outcome did not change (Additional
file 7: Figure S4).
Discussion
Here, we demonstrate that shotgun metagenomics can
facilitate the tracking of bacterial populations in FMT
experiments by linking their colonization trends to gen-
omic contexts through metagenome-assembled genomes
(MAGs). In our study, the relative abundance of MAGsin donor metagenomes did not predict whether they
would colonize the FMT recipients or not. However,
their success in colonizing the recipients mirrored their
occurrence in the large cohort of the Human Micro-
biome Project (HMP): the MAGs that colonized both of
our recipients were also found in many of the partici-
pants of the HMP, and the ones that colonized neither
of our recipients were missing in many. Besides suggest-
ing future directions to investigate the ecological and
functional basis of gut colonization, this observation
suggest that perhaps large-scale metagenomic surveys
can be useful to predict the colonization properties of
bacterial populations rapidly.
Previous studies reported an increase in the relative
abundance of Alistipes [23, 24, 54–56] and Bacteroides
populations after FMT experiments [23–26, 30]. The
success of the order Bacteroidales was also striking in
our dataset: 14 of the 20 group I Bacteroidales MAGs
we identified in the donor successfully colonized both
recipient guts. Although the taxonomic signal was rela-
tively strong, our results also showed that taxonomy is
not the sole predictor of transfer, as MAGs that resolved
to the same genera (i.e., Alistipes, Bacteroides, and Clos-
tridium) showed different colonization properties. In
addition, taxonomic annotation of a large fraction of
MAGs in our study did not resolve to a genus name,
which suggests that bacterial populations that have not yet
been characterized in culture collections may be playing
important roles in FMT treatments.
Although a substantial number of studies report success-
ful medical outcomes of FMT experiments [3, 7, 57, 58], a
complete understanding of this procedure from the
perspective of microbial ecology is still lacking. Studying
FMT as an ecological event and the identification of its key
components that facilitate the procedure’s success as a
Fig. 3 Similarity between donor and recipient samples before and
after FMT. Non-metric multidimensional scaling based on mean
coverage of 92 MAGs and based on microbial community profiles
from this study and 151 HMP metagenomes at the genus level of
short reads annotated by MetaPhlAn. Clustering employed average
linkage with Bray-Curtis similarity index on square-root normalized
values. Labels represent the recipients (R01, R02) before FMT (pre-FMT),
4 weeks (W4) and 8 weeks after FMT (W8). Gray circles represent
HMP metagenomes. Panel a displays changes in recipient microbial
community profiles after FMT based on coverage values of donor
MAGs. Panel b displays the organization of samples based on the
genus-level taxonomy of all short metagenomic reads in each sample.
In contrast, Panel c displays the genus organization of samples based
on the genus-level taxonomy of only short metagenomic reads that
do not match donor MAGs
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characterization of the transferred microbial populations at
an appropriate level of resolution. MAGs reconstructed
directly from donor samples can provide enough resolution
to guide cultivation efforts. A recent effort by Vineis et al.
[59] demonstrated this principle by first identifying bacter-
ial populations of interest using MAGs reconstructed from
a gut metagenome and then using the genomic context of
those MAGs to screen culture experiments from the
same gut sample to bring the target population to the
bench. A similar approach in the context of FMTs can
provide opportunities to design experiments to explore
the functional basis of colonization in controlled
systems.
The complete transfer of fecal matter between individuals
comes with various risks. For instance, a recent meta-
analysis of 50 peer-reviewed FMT case reports reported 38
potentially transfer-related adverse effects in FMT patients
in 35 studies, including fever, sore throat, vomiting, abdom-
inal pain, bowel perforation, rhinorrhea, transient relapse of
UC and CDI, and in one case, death, due to temporary
systemic immune response to the applied bacteria [60].
Besides bacteria, FMT can transfer viruses, archaea, and
fungi, as well as other agents of the donor host such as
colonocytes [61], which may affect the recipient’s biology in
unexpected ways. A more complete understanding of the
microbial ecology of FMTs could identify precisely what
needs to be transferred so that recipients benefit from the
positive outcomes of FMT without incurring medical risks
from uncharacterized biological material.
A recent study by Khanna et al. [62] reported high
rates of success with the treatment of patients with
primary Clostridium difficile infection (CDI) using an
investigational oral microbiome therapeutic, SER-109,
which contains bacterial spores enriched and purified
from healthy donors. However, Seres Therapeutics
announced more recently that interim findings from the
mid-stage clinical study of SER-109 failed to meet their
primary goal of reducing the risk of recurrence for up to
8 weeks [63]. In our study, the MAGs that failed to
colonize any of the recipients were significantly enriched
for spore-formation genes, and they also showed a very
sporadic distribution across the HMP cohort. Interest-
ingly, Nayfach et al. [64] recently made a similar
observation regarding the transmission of bacteria and
sporulation in a different system: vertical transmission of
bacteria between mothers and their infants. Bacterial
populations with high-vertical transmission rates had
lower number of genes related to sporulation [64]. These
observations suggest that excluding non-spore forming
bacteria may decrease the efficacy of FMT therapies due
to limited colonization efficiency, and deeper insights
into the functional basis of microbial colonization
require further study.
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Using bacterial populations associated with positive
health outcomes and that harbor high colonization
properties may result in more effective therapies com-
pared to cleansing all but spore-forming bacteria to
avoid the transfer of pathogens in FMT experiments.
The analytical strategy adopted in our study can provide
genomic insights into bacterial populations that may be
critical to the efficacy of FMT due to their success in gut
colonization and metabolic properties and guide cultiva-
tion efforts to investigate mechanistic underpinnings of
this procedure beyond associations.
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